Long-term treatment with recombinant insulin-like growth factor 1 (IGF-1) in a child with IGF-1 gene mutation

European Journal of Pediatrics

Volumn 169, Issue 2, 2010, Pages 245-247

  Concolino, Daniela ^a   Muzzi, Gianluca ^a   Sestito, Simona ^a   Vega, Giovanna ^a   Bonapace, Giuseppe ^a   Strisciuglio, Pietro ^a,b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

IGF 1 gene mutation; RhIGF 1 therapy

Indexed keywords

RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C;

ARTICLE; BODY HEIGHT; BODY MASS; CHILD; CLINICAL ASSESSMENT; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GENE MUTATION; GROWTH RATE; HEAD CIRCUMFERENCE; HORMONE DEFICIENCY; HUMAN; INSULIN LIKE GROWTH FACTOR DEFICIENCY; LONG TERM CARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

CHILD; DNA; DNA MUTATIONAL ANALYSIS; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN-LIKE GROWTH FACTOR I; LARON SYNDROME; MALE; MUTATION; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 77949423878     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-009-1004-2     Document Type: Article

References (10)

1. Bach LA (2004) The insulin-like growth factor system: towards clinical applications. Clin Biochem Rev 25(3):155-164.
2. Bonapace G, Concolino D, Formicola S, Strisciuglio P (2003) A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency. J Med Genet 40:913-917. doi:10.1136/jmg. 40.12.913.
3. Chernausek SD, Backeljauw PF, Frane J et al (2007) Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-1 deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab 92:902-910. doi:10.1210/jc.2006-1610.
4. Laron Z (2004) Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. J Clin Endocrinol Metab 89:1031-1044. doi:10.1210/jc.2003- 031033.
5. Laron Z (2008) Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity). Pediatr Endocrinol Rev 5:766-771.
6. Laron Z, Lilos P, Klinger B (1993) Growth curves for Laron syndrome. Arch Dis Child 68:768-770. doi:10.1136/adc. 68.6.768.
7. Laron Z, Roitman A, Kauli R (1979) Effect of human growth hormone therapy on head circumference in children with hypopituitarism. Clin Endocrinol (Oxf) 10(4):393-399. doi:10.1111/j.1365-2265.1979.tb02094.x.
8. Walenkamp MJE, Karperien M, Pereira AM et al (2005) Homozygous and heterozygous expression of a novel insulinlike growth factor-I mutation. J Clin Endocrinol Metab 90:2855- 2864. doi:10.1210/jc.2004-1254.
9. Woods KA, Camacho-Hübner C, Bergman RN et al (2000) Effects of insulin-like growth factor I (IGF-1) therapy on body composition and insulin resistance in IGF-1 gene deletion. J Clin Endocrinol Metab 85:1407-1411. doi:10.1210/jc.85.4.1407.
10. Woods KA, Camacho-Hübner C, Savage MO, AJLl C (1996) Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363-1367. doi:10.1056/NEJM199610 313351805.